Alle Storys
Folgen
Keine Story von Curasan AG mehr verpassen.

Curasan AG

ots Ad hoc-Service: curasan AG <DE0005494538> curasan AG increases its sales in 2000 by 38.6 percent

Ad hoc-announcement edited and sent by DGAP. The sender is solely
responsible for the contents of this announcement.
Kleinostheim(ots Ad hoc-Service) - curasan AG, Kleinostheim, could
increase its sales in the business year 2000 by 38.6 percent to 21.3
(15.4) million DM according to the final figures. The figures are
slightly above the provisional figure of 21.0 million DM published at
the end of December. The most important mainstay of growth was
biomaterials / biologicals with a strong increase of 70 percent to
8.5 (5.0) million DM. The field pharmaceuticals also experienced a
significant growth of 23.1 percent to 12.8 (10.4) million DM. The
gross profit was increased to 14.1 (10.0) million DM. With 40.7
percent this pleasant improvement was even stronger than the increase
of the overall performance of 39.4 percent. The EBIT in the group
amounted to minus 4.1 (minus 4.1) million DM and is better than the
provisional figures of minus 4.6 million DM. In total the profit and
loss account of curasan AG doses with an annual deficit in the group
of 3.5 (2.0) million DM. The result per share amounted to minus 0.59
(minus 1.09) DM. 
   For the business year 2001 the board expects an increase in sales
of 80 percent to 38 million DM with a break-even result after tax.
Curasan AG is currently preparing a product offensive which will
significantly increase the pace of growth. In the business year 2001
the market launch of up to 10 new products for different fields of
application is planned. The internationalisation within the European
Union, Eastern European countries, South America and the Middle East
is underway and will even be accelerated. It is planned to increase
the portion of sales generated abroad from currently 15 percent
(2000) to 45 percent until 2005.
Further information:
Helmut Trahmer, curasan AG. Tel 06027-46 86 0; email: 
ir@curasan.de Dr. Jürgen Gaulke, Gaulke & Partner Consult, Tel.
0177-679 30 60; email:  GaulkeJ@aol.com
WKN: 549453; Index: Listed: Neuer Markt Frankfurt; Freiverkehr in
Berlin, Bremen, Düsseldorf, Hamburg, Hannover, München und Stuttgart
End of message
Internet: http://recherche.newsaktuell.de

Original-Content von: Curasan AG, übermittelt durch news aktuell